Literature DB >> 33511685

Diabetes mellitus is not associated with enhanced bleeding risk in patients after percutaneous coronary intervention.

René M'Pembele1,2, Daniel Metzen1,2, Natalia Czychy1,2, Saif Zako1,2, Philipp Mourikis1,2, Carolin Helten1,2, Kajetan Trojovsky1,2, Denis Ignatov1,2, Tobias Petzold3, Manuela Thienel3, Lilian Vornholz1,2, Florian Bönner1,2, Bodo Levkau4, Tobias Zeus1, Malte Kelm1,2, Lisa Dannenberg1,2, Amin Polzin1,2.   

Abstract

Entities:  

Keywords:  aspects of diabetes; aspirin; bleeding; outcomes; percutaneous coronary intervention

Mesh：

Substances：

Year:  2021        PMID： 33511685     DOI： 10.1111/dme.14532

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  2 in total

1.  Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Yulong Li; Jiawen Li; Changdong Guan; Shuhong Su; Zhifang Wang; Haiwei Liu; Bo Xu; Weixian Yang; Yuejin Yang; Runlin Gao; Jinqing Yuan; Xueyan Zhao
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

2.  Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study.

Authors:  Hassan Alwafi; Ian C K Wong; Abdallah Y Naser; Amitava Banerjee; Pajaree Mongkhon; Cate Whittlesea; Alaa Alsharif; Li Wei
Journal:  Front Med (Lausanne)       Date:  2022-08-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.